Skip to main content
Filing year 2024

Vinnova

Portland, Oregon·EIN 84-2853743·NTEE G99 · Diseases, Disorders & Medical Disciplines·501(c)(3)
Total revenue
$4.4M
Total assets
$1.6M
Total expenses
$1.6M
Reported officers
4
Mission

Promote and support education, research, and develoment of drugs related to disease conditions where the microcirculation is affected; solcit donations from individuals and entities in support of the activities of the corporation

Reported officers (all unpaid)

No paid executives reported in 2024. Vinnova reported 4 unpaid officers and board members on its 990.

President
Treasurer
Director
Director

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

Financial trend

Revenue and expenses over time

Vinnova reported revenue and expenses across 2 filing years.

RevenueExpenses
$63k
$2k
2023
$4.4M
$1.6M
2024
Total revenue and total expenses from IRS Form 990 filings.
Sector benchmark

What Diseases, Disorders & Medical Disciplines executives earn

Vinnova reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable diseases, disorders & medical disciplines organization nationwide earns a median of $91,250.

25th percentile
$43k
Median
$91,250
75th percentile
$169k
90th percentile
$325k

These are diseases, disorders & medical disciplines sector-wide figures, not this organization's reported pay. Based on 2,397 organizations across 2,397 filings (2021 – 2024).

See full Diseases, Disorders & Medical Disciplines compensation data
FAQ

Common questions about Vinnova

What are Vinnova's revenue and expenses?

In 2024, Vinnova reported $4.4M in total revenue and $1.6M in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.